Circulating multimarker approach to identify patients with preclinical left ventricular remodelling and/or diastolic dysfunction.
Fiche publication
Date publication
février 2021
Journal
ESC heart failure
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Huttin O, Kobayashi M, Ferreira JP, Coiro S, Bozec E, Selton-Suty C, Filipetti L, Lamiral Z, Rossignol P, Zannad F, Girerd N
Lien Pubmed
Résumé
Biomarkers reflecting myocardial fibrosis and inflammation have been individually associated with left ventricular hypertrophy (LVH) and diastolic dysfunction (DD). However, the added value of a fibrosis-inflammation multimarker approach in a populational setting is yet to be studied. We evaluated the value of a multimarker approach to detect LVH and DD in a large population-based cohort.
Mots clés
Biomarkers, Brain natriuretic peptide, Collagen, Echocardiography, Doppler, Heart failure, diastolic, Left ventricle, Systolic function
Référence
ESC Heart Fail. 2021 Feb 12;: